Circio Holding ASA (OSL:CRNA)
Norway · Delayed Price · Currency is NOK 11.82
-0.06 (-0.51%)
Sep 18, 2026, 4:28 PM CET
Circio Holding ASA Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
11
Market Cap
3.25B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 123.00K | -9.88M | -98.77% |
| Dec 31, 2022 | 10.00M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 624.00K | -1.63M | -72.28% |
| Dec 31, 2019 | 2.25M | 2.22M | 8,237.04% |
| Dec 31, 2018 | 27.00K | -10.00K | -27.03% |
| Dec 31, 2017 | 37.00K | - | - |
| Dec 31, 2016 | 37.00K | -109.00K | -74.66% |
| Dec 31, 2015 | 146.00K | 74.00K | 102.78% |
| Dec 31, 2014 | 72.00K | -292.48K | -80.25% |
| Dec 31, 2013 | 364.48K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| ArcticZymes Technologies ASA | 133.41M |
| Arctic Bioscience AS | 48.96M |
| Oncoinvent ASA | 24.31M |
| SoftOx Solutions AS | 16.27M |
| Aqua Bio Technology ASA | 5.67M |
| Nykode Therapeutics AS | 4.60M |
| Thor Medical ASA | 1.64M |
| Lytix Biopharma ASA | 377.00K |
Circio Holding ASA News
- 18 days ago - Circio Holding ASA Earnings Call Transcript: Q2 2026 - Transcripts
- 18 days ago - Circio Holding ASA Quarterly report: Q2 2026 - Filings
- 18 days ago - Circio Holding ASA Slides: Q2 2026 - Filings
- 18 days ago - Circio Holding ASA Slides: Company presentation - Filings
- 3 months ago - Circio Holding ASA Slides: Investor update - Filings
- 4 months ago - Circio Holding ASA Slides: Corporate presentation - Filings
- 5 months ago - Circio Holding ASA Annual report: Q4 2025 - Filings
- 6 months ago - Circio Holding ASA Transcript: R&D update - Transcripts